|
| Press Releases |
|
 |
|
| Sunday, September 28, 2025 |
|
|
康哲药业（867.HK；8A8.SG）创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果 |
| 康哲药业控股有限公司（"康哲药业"）欣然宣布，旗下德镁医药有限公司（"德镁医药"，专业聚焦皮肤健康的创新型医药企业，正申请于香港联合交易所有限公司主板独立上市，详见康哲药业日期为2025年4月22日发布的公告）连同其附属公司取得磷酸芦可替尼乳膏（"芦可替尼乳膏"或"产品"）轻中度特应性皮炎（AD）的中国三期药物临床研究（"试验"）积极结果。 more info >> |
|
| Tuesday, September 23, 2025 |
|
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the "Agreements") with Chongqing Genrix Biopharmaceutical Co., Ltd. ("Genrix Bio") for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, "Vecantoxatug") indicated for passive immunization against tetanus and Silevimig Injection (GR1801, "Silevimig") indicated for passive immunization following suspected rabies virus exposure, respectively. more info >> |
|
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the "Agreements") with Chongqing Genrix Biopharmaceutical Co., Ltd. ("Genrix Bio") for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, "Vecantoxatug") indicated for passive immunization against tetanus and Silevimig Injection (GR1801, "Silevimig") indicated for passive immunization following suspected rabies virus exposure, respectively. more info >> |
|
|
康哲藥業就用於破傷風被動免疫和狂犬病被動免疫的兩款創新生物製劑達成合作 |
| 康哲藥業控股有限公司（「康哲藥業」）欣然宣佈，於2025年9月22日，通過其附屬公司與重慶智翔金泰生物製藥股份有限公司（「智翔金泰」）就兩款1類治療用生物製品分別簽訂獨家合作協議（「協議」），分別為用於破傷風的被動免疫適應症的唯康度塔單抗（GR2001）注射液（「唯康度塔單抗注射液」）以及用於疑似狂犬病病毒暴露後的被動免疫適應症的斯樂韋米單抗（GR1801）注射液（「斯樂韋米單抗注射液」）。 more info >> |
|
|
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作 |
| 康哲药业控股有限公司（"康哲药业"）欣然宣布，于2025年9月22日，通过其附属公司与重庆智翔金泰生物制药股份有限公司（"智翔金泰"）就两款1类治疗用生物制品分别签订独家合作协议（"协议"），分别为用于破伤风的被动免疫适应症的唯康度塔单抗（GR2001）注射液（"唯康度塔单抗注射液"）以及用于疑似狂犬病病毒暴露后的被动免疫适应症的斯乐韦米单抗（GR1801）注射液（"斯乐韦米单抗注射液"）。 more info >> |
|
| Tuesday, August 19, 2025 |
|
|
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers |
| more info >> |
|
|
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers |
| On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. more info >> |
|
| Tuesday, July 29, 2025 |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 22, 2025 |
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets |
| On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical Industry Growth Forum & CMS SGX Secondary Listing Appreciation Dinner". more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TaxiNexo Accelerates Global Expansion: Autonomous Taxis Arrive in Los Angeles
May 4, 2026 23:30 HKT/SGT
|
|
|
TaxiNexo Accelerates Global Expansion: Autonomous Taxis Arrive in Los Angeles
May 4, 2026 23:00: JST
|
|
|
As bossware backlash grows, Vaiz launches work management built on trust, not tracking
May 4, 2026 23:00: JST
|
|
|
As bossware backlash grows, Vaiz launches work management built on trust, not tracking
May 4, 2026 23:00 HKT/SGT
|
|
|
Pacific Avenue Capital Partners 就收購 ESE World（Amcor 旗下歐洲廢棄物容器業務）進入獨家談判
May 4, 2026 21:00 HKT/SGT
|
|
|
Pacific Avenue Capital Partners 就收购 ESE World（Amcor 旗下欧洲废弃物容器业务）进入独家谈判
May 4, 2026 21:00 HKT/SGT
|
|
|
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business
May 4, 2026 16:30: JST
|
|
|
Pacific Avenue Capital Partners、Amcorの欧州廃棄物容器事業「ESE World」の買収に向けた独占交渉を開始
May 4, 2026 16:30: JST
|
|
|
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business
May 4, 2026 15:30 HKT/SGT
|
|
|
6 Ways to Get More Rewards and Experiences from Everyday Spending
May 4, 2026 14:00 HKT/SGT
|
|
|
Breaking Through 'Chokepoint' Technology: China Risun's Hexamethylenediamine Plant Commenced Production
May 4, 2026 11:53 HKT/SGT
|
|
|
The 16th PropertyGuru Asia Property Awards (Singapore) introduces new categories as market adapts in 2026
May 4, 2026 11:00 HKT/SGT
|
|
|
Global Leaders Converge in Bangkok for the 18th Annual Global CSR & ESG Summit & Awards 2026
May 4, 2026 10:10 HKT/SGT
|
|
|
Taozhu New Creation Bureau Launches Dual-Store Rollout, Accelerating Shoucheng Holdings' (697.HK) Robotics Ecosystem Toward the Consumer Market
May 4, 2026 09:03 HKT/SGT
|
|
|
陶朱新造局雙店聯動 首程控股（697.HK）機器人生態加速走向消費端
May 4, 2026 09:03 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
